TickerFacts.

Rigel Pharmaceuticals Inc (RIGL): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$74.21M
Year ended 2022-12-31
$43.18M2009-12-31: -$102.92M2010-12-31: $43.18M2011-12-31: -$71.68M2012-12-31: -$88.59M2013-12-31: -$87.30M2014-12-31: -$70.17M2015-12-31: -$23.96M2016-12-31: -$76.69M2017-12-31: -$77.72M2018-12-31: -$59.93M2019-12-31: -$42.97M2020-12-31: -$53.45M2021-12-31: $5.25M2022-12-31: -$74.21M-$74.21M
2009-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$74.21Mn/m2025-03-04, From 2022-01-01
2021-12-31$5.25Mn/m2024-03-05, From 2021-01-01
2020-12-31-$53.45Mn/m2023-03-07, From 2020-01-01
2019-12-31-$42.97Mn/m2022-03-01, From 2019-01-01
2018-12-31-$59.93Mn/m2021-03-02, From 2018-01-01
2017-12-31-$77.72Mn/m2020-02-27, From 2017-01-01
2016-12-31-$76.69Mn/m2019-02-28, From 2016-01-01
2015-12-31-$23.96Mn/m2018-03-06, From 2015-01-01
2014-12-31-$70.17Mn/m2017-03-07, From 2014-01-01
2013-12-31-$87.30Mn/m2016-03-08, From 2013-01-01
2012-12-31-$88.59Mn/m2015-03-03, From 2012-01-01
2011-12-31-$71.68Mn/m2014-03-04, From 2011-01-01
2010-12-31$43.18Mn/m2013-03-05, From 2010-01-01
2009-12-31-$102.92Mn/a2012-03-06, From 2009-01-01